Bausch & Lomb (BLCO) Non-Current Debt (2022 - 2026)
Bausch & Lomb's (BLCO) quarterly Non-Current Debt came in at $5.1 billion in Q2 2026, up 2.38% YoY from $5.0 billion in Q2 2025, and up 0.75% on a QoQ basis from $5.0 billion in Q1 2026.
Bausch & Lomb (BLCO) Non-Current Debt (2022 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 5 years of Non-Current Debt data on file, last reported at $5.1 billion in Q2 2026.
- Quarterly Non-Current Debt rose 2.38% year-over-year to $5.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.1 billion (up 2.38% YoY) and the FY2025 annual result came in at $5.0 billion, up 5.52% from the prior year.
- Non-Current Debt climbed to $5.1 billion in Q2 2026, from $5.0 billion in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $5.1 billion in Q2 2026 to a low of $2.2 billion in Q1 2022.
- A 5-year average of $4.0 billion and a median of $4.6 billion in 2024 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2023 — Non-Current Debt jumped 87.27% — and 2026, when it climbed 2.38%.
- Tracing BLCO's Non-Current Debt over 5 years: stood at $2.4 billion in 2022, then jumped by 87.27% to $4.6 billion in 2023, then gained by 4.87% to $4.8 billion in 2024, then climbed by 5.52% to $5.0 billion in 2025, then grew by 0.57% to $5.1 billion in 2026.
- The last three Non-Current Debt figures came in at $5.1 billion (Q2 2026), $5.0 billion (Q1 2026), and $5.0 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 13.51 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 4.15 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 399.42 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 12.55 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 202.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 4.57 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 1.86 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 8.62 Bn |
| 10 | Bausch & Lomb | 6.16 Bn | 5.78 Bn | 867.00 Mn | 5.08 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.08 Bn |
| Mar 31, 2026 | 5.04 Bn |
| Dec 31, 2025 | 5.05 Bn |
| Sep 30, 2025 | 4.95 Bn |
| Jun 30, 2025 | 4.96 Bn |
| Mar 31, 2025 | 4.83 Bn |
| Dec 31, 2024 | 4.78 Bn |
| Sep 30, 2024 | 4.63 Bn |
| Jun 30, 2024 | 4.63 Bn |
| Mar 31, 2024 | 4.58 Bn |
| Dec 31, 2023 | 4.56 Bn |
| Sep 30, 2023 | 4.47 Bn |
| Jun 30, 2023 | 2.60 Bn |
| Mar 31, 2023 | 2.51 Bn |
| Dec 31, 2022 | 2.44 Bn |
| Sep 30, 2022 | 2.41 Bn |
| Jun 30, 2022 | 2.42 Bn |
| Mar 31, 2022 | 2.22 Bn |